Results 131 to 140 of about 6,234 (197)

[Acinetobacter baumannii pandrug-resistant: update in epidemiological and antimicrobial managing issues].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2006
In the last two decades Acinetobacter baumannii has emerged as a major relevant world nosocomial pathogen. A. baumannii can be a causal agent of diseases like pneumonia, bacteremia, meningitis, soft tissue and urinary tract infections, associating to high mortality. Several national and foreign communications reveal the isolation of A.
openaire   +1 more source

Large-area burns with pandrug-resistant Pseudomonas aeruginosa infection and respiratory failure.

Chinese medical journal, 2011
Infection due to pandrug-resistant Pseudomonas aeruginosa (PDRPA) has become a challenge in clinical practice. The aim of this research was to summarize the treatment of large-area burns (60% - 80%) with PDRPA infection and respiratory failure in our hospital over the last two years, and to explore a feasible treatment protocol for such patients.We ...
Fang-Gang, Ning, Xiao-Zhuo, Zhao, Jing, Bian, Guo-An, Zhang   +3 more
openaire   +1 more source

Pan-resistant Acinetobacter infection in neonates in Karachi, Pakistan. [PDF]

, 2009
Background: Pan-resistant Acinetobacter infection has emerged as an important nosocomial pathogen in our inPatient neonates over the past few years. Methodology: We performed a retrospective chart review during a five-year period (July 2003 - June 2008 ...
Ahmed, Imran, Ali, Syed Rehan, Mir, Fatima, Saleem, Ali Faisal, Zaidi, Anita K. M.   +4 more
core   +1 more source

Draft Genome Sequence of Pandrug-Resistant Pseudomonas aeruginosa SPA03, Isolated from a Patient with Benign Prostatic Hyperplasia. [PDF]

Microbiol Resour Announc, 2021
Pachi Pulusu C, Khamari B, Lama M, Peketi ASK, Kumar P, Nagaraja V, Bulagonda EP.   +6 more
europepmc   +1 more source

Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam. [PDF]

Sci Rep, 2021
Alghoribi MF, Alqurashi M, Okdah L, Alalwan B, AlHebaishi YS, Almalki A, Alzayer MA, Alswaji AA, Doumith M, Barry M.   +9 more
europepmc   +1 more source

Emergence and Inter- and Intrahost Evolution of Pandrug-Resistant <i>Klebsiella pneumoniae</i> Coharboring <i>tmexCD1-toprJ1, bla</i> _NDM-1, and <i>bla</i> _KPC-2. [PDF]

Microbiol Spectr, 2023
Liu C, Du P, Yang P, Zheng J, Yi J, Lu M, Shen N.   +6 more
europepmc   +1 more source

Mortality of Pandrug-Resistant Klebsiella pneumoniae Bloodstream Infections in Critically Ill Patients: A Retrospective Cohort of 115 Episodes. [PDF]

Antibiotics (Basel), 2021
Papadimitriou-Olivgeris M, Bartzavali C, Georgakopoulou A, Kolonitsiou F, Papamichail C, Spiliopoulou I, Christofidou M, Fligou F, Marangos M.   +8 more
europepmc   +1 more source

Pandrug-resistant Acinetobacter baumannii treatment: still a debatable topic with no definite solutions

Journal of Antimicrobial Chemotherapy, 2020
Georgios Papathanakos, Ioannis Andrianopoulos, Athanasios Papathanasiou, Despoina Koulenti, Konstantina Gartzonika, Vasilios Koulouras   +5 more
openaire   +3 more sources

Ceftazidime-avibactam for multidrug and pandrug-resistant gram-negative infections in critically Ill children: a single-center pediatric ıntensive care experience. [PDF]

Eur J Pediatr
Havan M, Arga G, Bülbül YE, Özerdem B, Eyduran E, Aslan AD, Penezoğlu N, İnceli HB, Öcal D, Özdemir H, Çiftci E, Kendirli T.   +11 more
europepmc   +1 more source

Thymoquinone combined with conventional antibiotics against pandrug-resistant <i>Staphylococcus aureus</i>: a pharmacodynamic and molecular simulation strategy to overcome bioavailability limitations. [PDF]

Front Pharmacol
Ahmad AAM, El-Naenaeey EYM, Elmowalid GA, Khamis T, Kandel TA, Khodeer DM, Orfali R, Abd El-Hamid MI.   +7 more
europepmc   +1 more source